Suraj Satpathy - Envista Holdings Chief officer

NVST Stock  USD 22.33  0.33  1.50%   

Executive

Suraj Satpathy is Chief officer of Envista Holdings Corp
Address Building E, Brea, CA, United States, 92821-6208
Phone714 817 7000
Webhttps://envistaco.com

Envista Holdings Management Efficiency

The company has return on total asset (ROA) of 0.0169 % which means that it generated a profit of $0.0169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3631) %, meaning that it created substantial loss on money invested by shareholders. Envista Holdings' management efficiency ratios could be used to measure how well Envista Holdings manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.04 in 2024. Return On Capital Employed is likely to drop to 0.01 in 2024. At this time, Envista Holdings' Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 7 B in 2024, whereas Non Current Liabilities Total is likely to drop slightly above 1.3 B in 2024.
Envista Holdings Corp currently holds 1.65 B in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Envista Holdings Corp has a current ratio of 1.09, suggesting that it may not be capable to disburse its financial obligations when due. Note, when we think about Envista Holdings' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Nicholas JDThe Cooper Companies,
50
Kerri DiPietroHaemonetics
N/A
Juan SernaAngioDynamics
N/A
Michelle FoxTeleflex Incorporated
N/A
Shiela VinczellerAptarGroup
60
Saleem CheeksAngioDynamics
N/A
Daniel AckermanAptarGroup
51
Clay FraddICU Medical
N/A
Jan MDHaemonetics
N/A
Lawrence KeuschTeleflex Incorporated
N/A
John CFAWest Pharmaceutical Services
N/A
Marna BronfenMooreAngioDynamics
57
Michele PolinskyWest Pharmaceutical Services
N/A
Laura PiccininiAngioDynamics
55
Nicholas KhadderThe Cooper Companies,
50
Dr CFAWest Pharmaceutical Services
57
Rudy PoussotWest Pharmaceutical Services
N/A
Howard CyrTeleflex Incorporated
N/A
Scott CenteaAngioDynamics
45
Agostino CPAThe Cooper Companies,
57
Marry SkafidasAptarGroup
N/A
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California. Envista Holdings operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 11200 people. Envista Holdings Corp (NVST) is traded on New York Stock Exchange in USA. It is located in Building E, Brea, CA, United States, 92821-6208 and employs 12,800 people. Envista Holdings is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Envista Holdings Corp Leadership Team

Elected by the shareholders, the Envista Holdings' board of directors comprises two types of representatives: Envista Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Envista. The board's role is to monitor Envista Holdings' management team and ensure that shareholders' interests are well served. Envista Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Envista Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Scott Huennekens, Independent Chairman of the Board
Amir Aghdaei, President, Chief Executive Officer, Director
Stephen Keller, Vice Relations
Paul Keel, CEO Director
Vivek Jain, Independent Director
Mischa Reis, Senior Vice President - Strategy and Corporate Development
Andrew Chen, Chief Officer
Christine Tsingos, Independent Director
Barbara Hulit, Independent Director
Gayle Sheppard, Independent Director
JeanClaude Kyrillos, Senior Vice President and President of the KaVo Kerr Business
Kieran Gallahue, Independent Director
Faez Kaabi, Chief VP
Suraj Satpathy, Chief officer
Daniel Raskas, Director
Juan Arbona, Chief Officer
Patrik Eriksson, Senior Vice President, President of the Nobel Biocare business
Wendy Carruthers, Independent Director
Eric Hammes, Chief Officer
Filippo Impieri, Senior Markets
Mark JD, General VP
Curt Bludworth, Chief Human Resource Officer, Senior Vice President
Mark Nance, Senior Vice President General Counsel, Secretary
Claudia Ortiz, Senior Assurance
Paul Sumilas, Chief Officer
Howard Yu, Chief Financial Officer, Senior Vice President
Eric Conley, VP Orthodontics
Jeffrey Kappler, Senior Vice President, President of the Ormco business

Envista Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Envista Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Envista Stock Analysis

When running Envista Holdings' price analysis, check to measure Envista Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Envista Holdings is operating at the current time. Most of Envista Holdings' value examination focuses on studying past and present price action to predict the probability of Envista Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Envista Holdings' price. Additionally, you may evaluate how the addition of Envista Holdings to your portfolios can decrease your overall portfolio volatility.